Core Lab Ecosystem

What Problems Do We Solve?

An Integrated Data Approach in Clinical Research, from Study Design to Analysis and from Analysis to Publication

In multi-center clinical studies, data consistency, traceability, and scientific quality are critical elements that affect the entire research lifecycle. These factors extend beyond the analysis phase and influence study design, sampling strategies, the selection of diagnostic kits, statistical evaluation approaches, clinical trial monitoring, and the transformation of results into scientific outputs.

The Omega ecosystem delivers integrated Core Lab solutions aimed at generating globally comparable and reliable data. This is achieved through a combination of central laboratory infrastructure, kit-based and validated analysis platforms, clinical research–ready methodologies, protocol-aligned statistical analysis frameworks, and continuous scientific and methodological oversight throughout the study lifecycle.

By ensuring methodological continuity across site operations, analytical processes, reporting, and manuscript preparation, this integrated structure strengthens scientific integrity and supports high-quality, end-to-end clinical research outcomes.

Core Lab Ecosystem

Laboratory, analytical, and operational services provided within the Omega ecosystem are delivered through Omega’s internal units or authorized partner infrastructures that comply with applicable standards, depending on the nature of the study, regulatory requirements, and methodological scope. Accreditations, certifications, and official authorizations apply at the level of the unit or partner organization where the service is actually performed and are assessed on a study-specific basis for each service category.

Sub Services

HelixLab

Supports the generation of reliable, comparable, and traceable analytical data through a central laboratory infrastructure specifically designed for clinical research. With protocol-aligned methodology and a robust quality framework spanning from study design to reporting, HelixLab forms the scientific backbone of Core Lab operations.

Omega Genetics

Provides integrated biomarker and pharmacogenomic approaches within genomic and molecular analyses tailored to clinical research design. Through validated methods and bioinformatics support, genetic data are translated into clinically and statistically meaningful outcomes.

Omega Biorepository

Manages the complete lifecycle of biological samples, from collection to long-term storage, with a strong focus on traceability and sample integrity. Delivers standardized sample management and retrieval infrastructure that underpins data quality in clinical research.

Animal Research Laboratory

Strengthens the scientific foundation of clinical development through ethical and regulation-compliant preclinical animal studies. Supports the generation of reliable, translationally relevant data prior to transition into clinical phases.

Home Services (Omega Care)

Delivers protocol-compliant home sampling and follow-up solutions that reduce site burden in clinical research. Securely integrates off-site data generation while maintaining visit windows, sample quality, and traceability requirements.

  • Genomic & Molecular Analyses
  • Microbiology
  • Viral Safety & Virology
  • Flow Cytometry
  • Safety Lab
  • Biorepository
  • Biomarker Development & Validation
  • Diagnostic Kits & Kit-Based Analysis Infrastructure
 

Scientific leadership and quality approach

Core Lab activities are managed in an integrated manner under a Scientific & Laboratory Directorate structure. This model is designed to ensure continuity of quality systems and preservation of methodological integrity. Biorepository operations are structured in alignment with GCLP (Good Clinical Laboratory Practice), CAP (College of American Pathologists), and ISBER (International Society for Biological and Environmental Repositories) guidelines.

Preclinical integration

For preclinical projects, a collaboration model with an accredited partner animal research laboratory operating under GLP and ISO/IEC 17025 standards.

Therapeutic areas

The Core Lab infrastructure is designed to support Phase I–IV clinical studies across multiple therapeutic areas. On the sample management side, emphasis is placed on oncology, cardiovascular, neurological, and metabolic diseases (to be fully detailed).

To quickly define the Core Lab scope for your study, sharing the following information is sufficient:

  • Therapeutic area / indication
  • Study phase and design summary
  • Sample types and visit windows
  • Required analytical domains
  • Reporting format and data transfer expectations
Request a Feasibility Call

The Omega ecosystem supports comparability of safety laboratory, coagulation, and immunology outputs across multicenter hematology studies. HelixLab central laboratory processes strengthen data consistency through defined sampling windows, pre-analytical standardization, and protocol-aligned reporting. Omega Biorepository ensures traceable storage and retrieval of materials such as serum, plasma, whole blood, Deoxyribonucleic Acid (DNA), and Ribonucleic Acid (RNA). Omega Genetics contributes to patient stratification and translational target support through biomarker and genetic validation components where appropriate.

Because biomarker strategy, sample management, and reporting standardization are critical in oncology studies, the Omega ecosystem provides end-to-end Core Lab coordination. HelixLab conducts molecular, cellular, and immunological workflows using protocol-aligned quality approaches while reducing site-to-site measurement variability in multicenter trials. Omega Genetics aims to translate genomics and molecular analyses related to tumor biology into clinical decision-support outputs through bioinformatics evaluation and structured data packages. Omega Biorepository provides the foundational infrastructure for long-term storage of tissue, liquid biopsy samples, and other biological materials while preserving audit trails.

In microbiology-focused studies, sample quality, visit windows, and contamination risk management are key determinants of result reliability. HelixLab standardizes culture-based approaches alongside molecular methods such as Polymerase Chain Reaction (PCR) and quantitative Polymerase Chain Reaction (qPCR) according to study requirements to generate comparable outputs. When needed, the Omega ecosystem can be configured with kit-based analytical infrastructure to strengthen methodological alignment between sites and the central laboratory. The OmegaCare home healthcare model supports traceability and sample integrity in protocol-compliant home sampling scenarios.

In cardiovascular studies, consistent measurement of safety biochemistry, lipid profiles, inflammatory markers, and selected biomarkers may be critical. HelixLab supports multicenter data comparability through protocol-driven panel configuration, critical value management, and standardized reporting. Omega Biorepository provides robust infrastructure for traceable storage of serial samples and management of stability requirements in longitudinal studies. Where appropriate, Omega Genetics may support research objectives with additional layers such as pharmacogenomics or risk markers.

Neurology studies often involve long follow-up periods, consistent longitudinal measurement, and strict data integrity requirements. HelixLab focuses on preserving longitudinal data quality through protocol-defined sampling windows and standardized analytical workflows. Omega Biorepository manages storage conditions and retrieval processes for sample types such as serum, plasma, and cerebrospinal fluid (CSF) in a traceable manner. For translational objectives, Omega Genetics contributes by interpreting molecular markers and preparing structured data packages to strengthen clinical research outputs.

In metabolic and endocrine studies, repeated sampling, biochemical parameter standardization, and structured data transfer are prominent considerations. HelixLab defines study panels according to protocol requirements and aligns reporting format and frequency with study operations. The OmegaCare home healthcare model can reduce site burden in suitable protocols through home sampling and follow-up while supporting visit window compliance. Omega Biorepository ensures sample integrity for long-term storage of serial samples and supports cross-analysis comparability.

In rheumatology studies, immunological markers, inflammatory indicators, and immunogenicity assessments related to biological therapies may become critical. HelixLab supports data quality by planning platforms such as Enzyme-Linked Immunosorbent Assay (ELISA) and, when required, cell-based neutralizing antibody assays according to study needs. The Omega ecosystem integrates sample management, reporting, and data transfer under a single coordination model to maintain methodological continuity between sites and laboratories. Omega Biorepository contributes to traceable storage of samples and preservation of audit trails in multi-visit studies.

In gastroenterology studies, sample diversity (blood, stool, tissue) and pre-analytical standardization create significant complexity. HelixLab enhances comparability in multicenter studies by standardizing sample acceptance criteria, processing steps, and reporting dictionaries according to protocol. In studies involving microbiome or translational targets, sample processing and storage infrastructure are among the primary determinants of result reliability. Omega Biorepository manages appropriate storage conditions and traceable retrieval processes for stool and other biological materials.

In pulmonary studies, respiratory samples, infection-related assessments, and immune response indicators are frequently central. HelixLab supports data standardization through quality triage approaches for swab and respiratory samples, molecular testing, and protocol-aligned reporting. In suitable designs, viral load or serological assessments may provide complementary layers that can be interpreted alongside clinical outcomes. The OmegaCare home healthcare model can enhance patient compliance and visit window management through protocol-compliant home sampling and follow-up.

Translational research requires an integrated approach that connects clinical data with biological mechanisms and biomarker layers. The Omega ecosystem supports this integration under a single coordination model through HelixLab central laboratory operations, Omega Genetics’ molecular capabilities, and Omega Biorepository’s sample lifecycle management. Test selection, method verification, and data package structuring are planned according to study objectives to translate analytical outputs into clinical relevance. This structure contributes to reduced measurement variability and preservation of data integrity in multicenter studies.

In biomarker-focused studies, the most critical factor is controlling sampling and analytical variability. HelixLab structures method selection and quality control plans on a study-specific basis according to sample matrix, visit windows, and analyte characteristics. Omega Genetics adds an expert layer for interpretation and reporting of genomic and molecular biomarkers where appropriate. Omega Biorepository provides infrastructure that meets requirements for serial sample storage, retrieval, and traceability essential to biomarker studies.

In cell and gene therapy studies, sample integrity, viral safety, cellular characterization, and auditability are more sensitive than in conventional studies. HelixLab supports high regulatory expectations through pre-analytical standardization, chain-of-custody traceability, and protocol-aligned reporting. Omega Biorepository is positioned to strengthen traceability and business continuity in cryogenic storage and transfer processes. Where appropriate, Omega Genetics may support research objectives with vector- or target-specific molecular validation components.

In CAR-T and advanced therapies, characterization of cellular products, safety assessments, and time-critical sampling windows are operationally and scientifically decisive. HelixLab aims to generate comparable data by standardizing cellular analysis workflows and selected viral safety assessments according to study requirements. Omega Biorepository provides a traceable sample lifecycle management approach for storage, monitoring, and retrieval of cellular materials. The Omega ecosystem focuses on unifying site operations and laboratory processes within a single coordinated workflow.

Because preclinical research forms the scientific basis for transition into clinical phases, methodological consistency and data quality are critical. The Omega ecosystem aims to support generation of high translational value data by combining partner preclinical infrastructure with a clinical research perspective. Sample management, analytical planning, and reporting approaches can be structured in alignment with clinical development requirements based on study objectives. This integration contributes to stronger linkage between preclinical findings and clinical programs.

Animal models play a critical role in early decision points such as mechanism validation, safety assessment, and biomarker discovery. The Omega ecosystem is positioned to connect study planning in partner animal research laboratories with traceable management of generated biological material. Where appropriate, HelixLab and Omega Biorepository processes can provide integrated workflows for standardized processing, storage, and preparation of samples for analytical evaluation, aligning preclinical data more closely with clinical development goals.